Skip to main content
. 2021 Nov 5;45(5):838–846. doi: 10.1016/j.bj.2021.10.013

Table 2.

Treatment response based on RECIST or PET.

Response RECIST PET
CR/CMR 15 (25.0%) 13 (21.7%)
PR/PMR 37 (41.6%) 31 (51.7%)
SD/SMD 7 (11.7%) 8 (13.3%)
PD/PMD 13 (21.7%) 8 (13.3%)
Total 72 (100%) 60 (100%)

Abbreviations: RECIST: Response Evaluation Criteria in Solid Tumors; PET: positron emission tomography; CR: complete response; CMR: complete metabolic response; PR: partial response; PMR: partial metabolic response; SD: stable disease; SMD: stable metabolic disease; PD: progressive disease; PMD: progressive metabolic disease. The response of PET is based on the criteria of European Organization for Research and Treatment of Cancer (EORTC) recommendations [13].